- Home
- FENC vs ZTR Comparison
FENC vs ZTR Comparison
Compare FENC & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$10.76
Company Overview
Basic Information| Metric | FENC | ZTR |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 342.5M |
| IPO Year | 2010 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FENC | ZTR |
|---|---|---|
| Price | $10.76 | $6.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | ★ 243.7K | 97.1K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | N/A |
| P/E Ratio | $179.67 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $6.17 |
| 52 Week High | $13.25 | $7.11 |
Technical Indicators
Market Signals| Indicator | FENC | ZTR |
|---|---|---|
| Relative Strength Index (RSI) | 40.04 | 24.47 |
| Support Level | $9.74 | $6.23 |
| Resistance Level | $11.28 | $6.89 |
| Average True Range (ATR) | 0.58 | 0.09 |
| MACD | -0.24 | -0.05 |
| Stochastic Oscillator | 19.77 | 9.09 |
Price Performance
Historical Comparison FENC
ZTR
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.